Literature DB >> 11576777

Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro.

G Betz1, P Nowbakht, R Imboden, G Imanidis.   

Abstract

The transport of unfractionated (UH) and low molecular weight Heparin (LMWH) in human skin was investigated in vitro using heat separated epidermal membrane and dermis and the effect of liposomal formulations with Phospholipon(R) 80 (PL80) and Sphingomyelin (SM) was assessed. The distribution of Heparin within skin tissue was studied by the tape stripping method. Heparin concentrations were measured with a biological assay. Transepidermal water loss was determined to characterize barrier properties of skin. No consistent permeation of Heparin through epidermal membrane was detected. Penetration into the epidermal membrane was for LMWH significantly greater than for UH. Accumulation of UH was largely restricted to the outermost layers of the stratum corneum while LMWH penetrated into deeper epidermal layers. UH penetration into epidermis was detected for the PL80 liposomal formulation only. The extent of LMWH penetration was independent of the formulation, LMWH, however, showed a trend to accumulate in deeper epidermal layers for the PL80 compared to the aqueous formulation. Thus, molecular weight and liposomal formulations influenced the penetration pattern of Heparin in the epidermis. It can not be concluded whether the concentration of LMWH achieved at the blood capillaries is sufficient to exert a pharmacological effect. UH permeated readily through dermis irrespectively of formulation and its accumulation in the dermis was significantly enhanced and its lag time of permeation increased in the presence of SM liposomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576777     DOI: 10.1016/s0378-5173(01)00832-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomes.

Authors:  Vijay Prajapati; Aakanchha Jain; Richa Jain; Sanjeev Sahu; Dharm Veer Kohli
Journal:  Drug Deliv Transl Res       Date:  2014-12       Impact factor: 4.617

Review 2.  The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins.

Authors:  Nusrat A Motlekar; Bi-Botti C Youan
Journal:  J Control Release       Date:  2006-06-14       Impact factor: 9.776

3.  Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium.

Authors:  Yasmine A Gomaa; Martin J Garland; Fiona McInnes; Labiba K El-Khordagui; Clive Wilson; Ryan F Donnelly
Journal:  Eur J Pharm Biopharm       Date:  2012-07-23       Impact factor: 5.571

4.  Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea.

Authors:  Jianxing Zhang; Xiaoyu Xu; Narayanam V Rao; Brian Argyle; Lindsi McCoard; William J Rusho; Thomas P Kennedy; Glenn D Prestwich; Gerald Krueger
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

Review 5.  Strategies to Overcome Heparins' Low Oral Bioavailability.

Authors:  Ana Rita Neves; Marta Correia-da-Silva; Emília Sousa; Madalena Pinto
Journal:  Pharmaceuticals (Basel)       Date:  2016-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.